Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03437824 · ClinicalTrials.gov registry record · Early Phase 1
Effects of Vitamin B12 Treatment in Singers
A Early Phase 1 study, sponsored by University of Southern California.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 20
- Enrollment target
NCT03437824 is a Early Phase 1 study that has completed, run by University of Southern California. The registered enrollment target is 20 participants.
The verdict
NCT03437824, a Early Phase 1 study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
In this study, the investigators aim to assess if vitamin B12 treatment demonstrates a beneficial effect on voice performance. If so, they wish to examine the relationship between the vitamin B12 treatment and the study participant's general well-being.
Interventions
- DRUG Placebo
- DRUG Cyanocobalamin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-10-01 |
| Est. Completion | 2019-04-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03437824
The ClinicalTrials.gov registry entry for NCT03437824 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03437824 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03437824 about?
NCT03437824 is a clinical study titled "Effects of Vitamin B12 Treatment in Singers". In this study, the investigators aim to assess if vitamin B12 treatment demonstrates a beneficial effect on voice performance. If so, they wish to examine the relationship between the vitamin B12 treatment and the study participant's general well-being.
What is the current status of trial NCT03437824?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 20 participants. The study started on 2017-10-01. Estimated completion is 2019-04-01.
What interventions are being tested in trial NCT03437824?
The interventions under investigation include: Placebo (DRUG), Cyanocobalamin (DRUG).
Who is sponsoring clinical trial NCT03437824?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.